An international team of researchers examined genetic and lifestyle factors linked to heart disease in some 55,600 people.
By analyzing the transcriptomes of more than 4,000 individual cells, researchers identified stem cell-like cellular subpopulations in six oligodendroglioma tumors.
The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis.
The healthcare provider organizations are tasked with managing patient enrollment in the Precision Medicine Initiative.
Nature News writes that efforts like ExAC are enabling researchers to call some seemingly disease-linked variants as benign.
The Broad Institute-led team has published its procedures, preliminary findings, and possible future applications for the consortium's open access database.
By comparing pre-treatment and post-relapse samples from vemurafenib-treated melanoma patients, researchers uncovered resistance-related cohesin complex mutations.
The Massachusetts-based clinical gene editing firm has obtained exclusive rights to use the engineered Cas9 variants developed by one of its co-founders.
With genotypes for hundreds of thousands of individuals, investigators uncovered 15 loci linked to major depressive disorder in individuals with European ancestry.
Researchers working on the Human Functional Genomics Project have begun to unravel genetic relationships and variations in human immune response.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.